| ACovPid | Against Virus | Inhibition Value Type | Inhibitory Effect | Inhibitory Unit | Target Domain Name | Detail |
|---|---|---|---|---|---|---|
| ACoVP100001 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 0.0365 | µM | HR1 domain of SARS-CoV-2 | more |
| ACoVP100002 | Middle East respiratory syndrome-related coronavirus (isolate United Kingdom/H123990006/2012) (MERS-CoV) (Betacoronavirus England 1) : 1263720 | IC50 | 0.0042 | µM | HR1 domain of MERS-CoV (Betacoronavirus England 1) | more |
| ACoVP100003 | Human coronavirus OC43 (HCoV-OC43) : 31631 | IC50 | 0.0248 | µM | HR1 domain of HCoV-OC43 | more |
| ACoVP100004 | Human coronavirus 229E (HCoV-229E) : 11137 | IC50 | 0.1015 | µM | HR1 domain of HCoV-229E | more |
| ACoVP100005 | Human coronavirus NL63 (HCoV-NL63) : 277944 | IC50 | 0.1876 | µM | HR1 domain of HCoV-NL63 | more |
| ACoVP100006 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 0.2867 | µM | HR1 domain of SARS-CoV-2 | more |
| ACoVP100007 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 0.0481 | µM | HR1 domain of SARS-CoV-2 | more |
| ACoVP100008 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 0.0692 | µM | HR1 domain of SARS-CoV-2 | more |
| ACoVP100009 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 0.0568 | µM | HR1 domain of SARS-CoV-2 | more |
| ACoVP100010 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 0.0482 | µM | HR1 domain of SARS-CoV-2 | more |
| ACoVP100011 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 0.0106 | µM | HR1 domain of SARS-CoV-2 | more |
| ACoVP100012 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 0.0013 | µM | HR1 domain of SARS-CoV-2 | more |
| ACoVP100013 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 0.0031 | µM | HR1 domain of SARS-CoV-2 | more |
| ACoVP100014 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 0.0039 | µM | HR1 domain of SARS-CoV-2 | more |
| ACoVP100015 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 0.0039 | µM | HR1 domain of SARS-CoV-2 | more |
| ACoVP100016 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 2.375 | µM | HR1 domain of SARS-CoV-2 | more |
| ACoVP100017 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 0.1394 | µM | HR1 domain of SARS-CoV-2 | more |
| ACoVP100018 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 0.4803 | µM | HR1 domain of SARS-CoV-2 | more |
| ACoVP100019 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 0.4186 | µM | HR1 domain of SARS-CoV-2 | more |
| ACoVP100020 | Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2) : 2697049 | IC50 | 0.0864 | µM | HR1 domain of SARS-CoV-2 | more |